Literature DB >> 20038610

Role for the regulator of G-protein signaling homology domain of G protein-coupled receptor kinases 5 and 6 in beta 2-adrenergic receptor and rhodopsin phosphorylation.

Faiza Baameur1, Daniel H Morgan, Hui Yao, Tuan M Tran, Richard A Hammitt, Subir Sabui, John S McMurray, Olivier Lichtarge, Richard B Clark.   

Abstract

Phosphorylation of G protein-coupled receptors (GPCRs) by GPCR kinases (GRKs) is a major mechanism of desensitization of these receptors. GPCR activation of GRKs involves an allosteric site on GRKs distinct from the catalytic site. Although recent studies have suggested an important role of the N- and C-termini and domains surrounding the kinase active site in allosteric activation, the nature of that site and the relative roles of the RH domain in particular remain unknown. Based on evolutionary trace analysis of both the RH and kinase domains of the GRK family, we identified an important cluster encompassing helices 3, 9, and 10 in the RH domain in addition to sites in the kinase domain. To define its function, a panel of GRK5 and -6 mutants was generated and screened by intact-cell assay of constitutive GRK phosphorylation of the beta(2)-adrenergic receptor (beta 2AR), in vitro GRK phosphorylation of light-activated rhodopsin, and basal catalytic activity measured by tubulin phosphorylation and autophosphorylation. A number of double mutations within helices 3, 9, and 10 reduced phosphorylation of the beta2AR and rhodopsin by 50 to 90% relative to wild-type GRK, as well as autophosphorylation and tubulin phosphorylation. Based on these results, helix 9 peptide mimetics were designed, and several were found to inhibit rhodopsin phosphorylation by GRK5 with an IC(50) of approximately 30 microM. In summary, our studies have uncovered previously unrecognized functionally important sites in the regulator of G-protein signaling homology domain of GRK5 and -6 and identified a peptide inhibitor with potential for specific blockade of GRK-mediated phosphorylation of receptors.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20038610      PMCID: PMC2835418          DOI: 10.1124/mol.109.058115

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN: 0026-895X            Impact factor:   4.436


  39 in total

1.  A family of evolution-entropy hybrid methods for ranking protein residues by importance.

Authors:  I Mihalek; I Res; O Lichtarge
Journal:  J Mol Biol       Date:  2004-03-05       Impact factor: 5.469

2.  Regulation of the G protein-coupled receptor kinase GRK5 by protein kinase C.

Authors:  A N Pronin; J L Benovic
Journal:  J Biol Chem       Date:  1997-02-07       Impact factor: 5.157

3.  Intrinsic secondary structure propensities of the amino acids, using statistical phi-psi matrices: comparison with experimental scales.

Authors:  V Muñoz; L Serrano
Journal:  Proteins       Date:  1994-12

4.  An evolutionary trace method defines binding surfaces common to protein families.

Authors:  O Lichtarge; H R Bourne; F E Cohen
Journal:  J Mol Biol       Date:  1996-03-29       Impact factor: 5.469

5.  Differential expression of the beta-adrenergic receptor modifies agonist stimulation of adenylyl cyclase: a quantitative evaluation.

Authors:  B S Whaley; N Yuan; L Birnbaumer; R B Clark; R Barber
Journal:  Mol Pharmacol       Date:  1994-03       Impact factor: 4.436

6.  A mutation-induced activated state of the beta 2-adrenergic receptor. Extending the ternary complex model.

Authors:  P Samama; S Cotecchia; T Costa; R J Lefkowitz
Journal:  J Biol Chem       Date:  1993-03-05       Impact factor: 5.157

7.  Expression, purification, and characterization of the G protein-coupled receptor kinase GRK6.

Authors:  R P Loudon; J L Benovic
Journal:  J Biol Chem       Date:  1994-09-09       Impact factor: 5.157

8.  Light-dependent phosphorylation of rhodopsin: number of phosphorylation sites.

Authors:  U Wilden; H Kühn
Journal:  Biochemistry       Date:  1982-06-08       Impact factor: 3.162

9.  G Protein-coupled receptor kinase 2 regulator of G protein signaling homology domain binds to both metabotropic glutamate receptor 1a and Galphaq to attenuate signaling.

Authors:  Gurpreet K Dhami; Lianne B Dale; Pieter H Anborgh; Katharine E O'Connor-Halligan; Rachel Sterne-Marr; Stephen S G Ferguson
Journal:  J Biol Chem       Date:  2004-02-04       Impact factor: 5.157

10.  Identification of the N-terminal region in rhodopsin kinase involved in its interaction with rhodopsin.

Authors:  K Palczewski; J Buczyłko; L Lebioda; J W Crabb; A S Polans
Journal:  J Biol Chem       Date:  1993-03-15       Impact factor: 5.157

View more
  35 in total

1.  Evolution-guided discovery and recoding of allosteric pathway specificity determinants in psychoactive bioamine receptors.

Authors:  Gustavo J Rodriguez; Rong Yao; Olivier Lichtarge; Theodore G Wensel
Journal:  Proc Natl Acad Sci U S A       Date:  2010-04-12       Impact factor: 11.205

2.  Sequence and structure continuity of evolutionary importance improves protein functional site discovery and annotation.

Authors:  A D Wilkins; R Lua; S Erdin; R M Ward; O Lichtarge
Journal:  Protein Sci       Date:  2010-07       Impact factor: 6.725

Review 3.  G protein-coupled receptors: novel targets for drug discovery in cancer.

Authors:  Rosamaria Lappano; Marcello Maggiolini
Journal:  Nat Rev Drug Discov       Date:  2011-01       Impact factor: 84.694

4.  G protein-coupled receptor kinases: Past, present and future.

Authors:  Konstantin E Komolov; Jeffrey L Benovic
Journal:  Cell Signal       Date:  2017-07-12       Impact factor: 4.315

Review 5.  The functional importance of co-evolving residues in proteins.

Authors:  Inga Sandler; Nitzan Zigdon; Efrat Levy; Amir Aharoni
Journal:  Cell Mol Life Sci       Date:  2013-09-01       Impact factor: 9.261

Review 6.  G protein-coupled receptor kinases: more than just kinases and not only for GPCRs.

Authors:  Eugenia V Gurevich; John J G Tesmer; Arcady Mushegian; Vsevolod V Gurevich
Journal:  Pharmacol Ther       Date:  2011-08-26       Impact factor: 12.310

Review 7.  Targeting kinase signaling pathways with constrained peptide scaffolds.

Authors:  Laura E Hanold; Melody D Fulton; Eileen J Kennedy
Journal:  Pharmacol Ther       Date:  2017-02-07       Impact factor: 12.310

Review 8.  Evolution: a guide to perturb protein function and networks.

Authors:  Olivier Lichtarge; Angela Wilkins
Journal:  Curr Opin Struct Biol       Date:  2010-05-03       Impact factor: 6.809

9.  Combinatorial inhibition of PTPN12-regulated receptors leads to a broadly effective therapeutic strategy in triple-negative breast cancer.

Authors:  Amritha Nair; Hsiang-Ching Chung; Tingting Sun; Siddhartha Tyagi; Lacey E Dobrolecki; Rocio Dominguez-Vidana; Sarah J Kurley; Mayra Orellana; Alexander Renwick; David M Henke; Panagiotis Katsonis; Earlene Schmitt; Doug W Chan; Hui Li; Sufeng Mao; Ivana Petrovic; Chad J Creighton; Carolina Gutierrez; Julien Dubrulle; Fabio Stossi; Jeffrey W Tyner; Olivier Lichtarge; Charles Y Lin; Bing Zhang; Kenneth L Scott; Susan G Hilsenbeck; Jinpeng Sun; Xiao Yu; C Kent Osborne; Rachel Schiff; James G Christensen; David J Shields; Mothaffar F Rimawi; Matthew J Ellis; Chad A Shaw; Michael T Lewis; Thomas F Westbrook
Journal:  Nat Med       Date:  2018-03-26       Impact factor: 53.440

10.  Molecular defects in human carbamoy phosphate synthetase I: mutational spectrum, diagnostic and protein structure considerations.

Authors:  Johannes Häberle; Oleg A Shchelochkov; Jing Wang; Panagiotis Katsonis; Lynn Hall; Sara Reiss; Angela Eeds; Alecia Willis; Meeta Yadav; Samantha Summar; Olivier Lichtarge; Vicente Rubio; Lee-Jun Wong; Marshall Summar
Journal:  Hum Mutat       Date:  2011-05-05       Impact factor: 4.878

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.